首页> 外文期刊>BMC Medical Genomics >Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis
【24h】

Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis

机译:通过综合分析鉴定全中心B细胞型弥漫性大B细胞淋巴瘤的超强增强剂相关键基因

获取原文
           

摘要

The pathogenesis of germinal center B-cell type diffuse large B-cell lymphoma (GCB-DLBCL) is not fully elucidated. This study aims to explore the regulation of super enhancers (SEs) on GCB-DLBCL by identifying specific SE-target gene. Weighted gene co-expression network analysis (WGCNA) was used to screen modules associated with GCB subtype. Functional analysis was performed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. H3K27ac peaks were used to identify SEs. Overall survival analysis was performed using Kaplan–Meier curve with log-rank and Breslow test. The effect of ADNP, ANKRD28 and RTN4IP1 knockdown on Karpas 422 and SUDHL-4 cells proliferation was analyzed by CCK-8. Karpas 422 and SUDHL-4 cells were treated with bromodomain and extra-terminal domain (BET) inhibitor JQ1, and the expression of ADNP, ANKRD28 and RTN4IP1was measured by qRT-PCR. A total of 26 modules were screened in DLBCL. Turquoise module was closely related to GCB-DLBCL, and its eigengenes were mainly related to autophagy. There were 971 SEs in Karpas 422 cell and 1088 SEs in SUDHL-4 cell. Function of the nearest genes of overall SEs were related to cancer. Six SE-related genes associated with GCB-DLBCL were identified as prognostic markers. Knockdown of ADNP, ANKRD28 and RTN4IP1 inhibited the proliferation of Karpas 422 and SUDHL-4 cells. JQ1 treatment suppressed ADNP, ANKRD28 and RTN4IP1 expression in Karpas 422 and SUDHL-4 cells. A total of 6 SE-related genes associated with GCB-DLBCL overall survival were identified in this study. These results will serve as a theoretical basis for further study of gene regulation and function of GCB-DLBCL.
机译:未充分阐明生发中心B细胞型扩散大B细胞淋巴瘤(GCB-DLBCL)的发病机制。本研究旨在通过鉴定特异性SE-靶基因探讨超强增强剂(SES)对GCB-DLBCL的调节。加权基因共表达网络分析(WGCNA)用于筛选与GCB亚型相关的模块。通过基因本体(GO)和基因组(KEGG)富集的基因本体(GO)和Kyoto百科全书进行功能分析。 H3K27AC峰被用于识别SES。使用Kaplan-Meier曲线进行整体生存分析,带有日志秩和Breslow测试。通过CCK-8分析了ADNP,ANKRD28和RTN4IP1敲低对karpas 422和sudhl-4细胞增殖的影响。用溴琼瓜和超末端结构域(BET)抑制剂JQ1处理Karpas 422和SudHL-4细胞,以及通过QRT-PCR测量的ADNP,ANKRD28和RTN4IP1的表达。在DLBCL中筛选了总共26个模块。绿松石模块与GCB-DLBCL密切相关,其EIGENGENS主要与自噬有关。在karpas 422细胞中有971次,Sudhl-4细胞中的1088次。最近的总体SES的功能与癌症有关。与GCB-DLBCL相关的六种相关基因被鉴定为预后标志物。 ADNP,ANKRD28和RTN4IP1的敲低抑制了karpas 422和sudhl-4细胞的增殖。 JQ1处理抑制了karpas 422和sudhl-4细胞中的ADNP,ANKRD28和RTN4IP1表达。在本研究中确定了总共相关的与GCB-DLBCL总存活相关的相关基因。这些结果将作为进一步研究GCB-DLBCL的基因调控和功能的理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号